A carregar...
Synthesized OVA(323-339)MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells
BACKGROUND: Antigen-specific immunotherapy (SIT) has been widely practiced in treating allergic diseases such as asthma. However, this therapy may induce a series of allergic adverse events during treatment. Peptide immunotherapy (PIT) was explored to overcome these disadvantages. We confirmed that...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3472185/ https://ncbi.nlm.nih.gov/pubmed/22769043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2172-13-34 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|